The Endometrial Receptivity Array (ERA) is an advanced genetic test designed to determine the optimal timing for embryo transfer during an IVF cycle. This test evaluates the receptivity of the endometrial lining by analyzing the expression of specific genes that indicate when the uterus is most prepared for implantation. Since every woman’s implantation window can vary, ERA provides a personalized approach to embryo transfer, significantly improving the chances of a successful pregnancy.
ERA is especially beneficial for women who have experienced repeated IVF failures, unexplained infertility, or conditions affecting the endometrial lining, such as endometriosis or hormonal imbalances. By precisely identifying the implantation window, this test helps fertility specialists time the embryo transfer with greater accuracy, ensuring the highest likelihood of success. At Bud IVF, we integrate ERA into personalized fertility treatment plans to maximize implantation potential and support your journey toward parenthood.
ERA testing is recommended for patients who:
If you’ve gone through multiple IVF cycles without success, ERA can help identify whether the timing of embryo transfer may be the issue.
For couples with no clear reason for infertility, ERA testing can help uncover hidden causes related to the endometrium’s receptivity.
If you’ve experienced multiple miscarriages, ERA can help assess whether your endometrium is optimally prepared to support pregnancy.
Women diagnosed with endometriosis, fibroids, or polyps may benefit from ERA testing to ensure their endometrial lining is receptive enough for embryo implantation.
If you have hormonal issues that might affect the timing of your natural cycle or IVF, ERA can help pinpoint the best time for embryo transfer.
The ERA procedure involves a simple biopsy of the endometrial lining. Here’s how it’s done:
At Bud IVF, we strive to make your IUI journey a stress-free and successful experience. Here’s why we are the preferred choice for couples seeking fertility treatment.
By determining the optimal window of implantation, ERA helps increase the likelihood of successful embryo implantation and pregnancy.
ERA offers a more tailored approach to IVF treatment by ensuring the right timing for embryo transfer, which is crucial for achieving success.
ERA testing reduces the risk of failed cycles by ensuring that the embryos are transferred at the most receptive stage of the uterine lining.
ERA can help identify issues that may contribute to repeated miscarriages, improving the chances of a successful pregnancy.
The success rate of ERA testing is high, with a 90% accuracy in determining the optimal implantation window. This precision can significantly improve IVF outcomes, especially for women who have undergone multiple failed cycles. ERA results help identify the most appropriate time for embryo transfer, maximizing the chances of success.
However, there are several factors that can influence the outcome of ERA testing:
The ERA is a diagnostic test that evaluates the optimal time for embryo transfer by analyzing the genetic expression of the endometrial lining. It identifies the “receptive window” when the uterus is most likely to accept an embryo for implantation.
Talk on Whatsapp